22157.jpg
Global Oncology Targeted Immunotherapy Market Research Report 2021: Developments in Biotechnology Platforms Leading to Increasing Immuno-oncology Applications
January 20, 2022 04:08 ET | Research and Markets
Dublin, Jan. 20, 2022 (GLOBE NEWSWIRE) -- The "Targeted Immunotherapy in Oncology" report has been added to ResearchAndMarkets.com's offering. This research service investigates technologies that...
22157.jpg
Global Immunology Partnering 2021 Report: Deal Trends, Players and Financials
December 22, 2021 05:03 ET | Research and Markets
Dublin, Dec. 22, 2021 (GLOBE NEWSWIRE) -- The "Global Immunology Partnering 2014-2021: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. Global...
logo.jpg
TIGIT Inhibitor In Clinical Trials As Targeted Cancer Immunotherapy
December 09, 2021 02:40 ET | KuicK Research
Delhi, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Global TIGIT Inhibitor Drug Opportunity & Clinical Research Insight 2022 Report Highlights: Global TIGIT Inhibitor Market DynamicsClinical Approaches to...
22157.jpg
Global Cancer Immunotherapy Market Research Report 2021
October 22, 2021 04:13 ET | Research and Markets
Dublin, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Market by Product Type, Application, End Users, and Geography - Global Forecast up to 2026" report has been added to...
22157.jpg
TIL-based Therapies Market by Target Indications, Key Players and Key Geographies - Global Industry Trends and Forecasts, 2021-2030
July 23, 2021 04:13 ET | Research and Markets
Dublin, July 23, 2021 (GLOBE NEWSWIRE) -- The "TIL-based Therapies Market by Target Indications, Key Players and Key Geographies: Industry Trends and Global Forecasts, 2021-2030" report has been...
CLS-Logo-1.jpg
Scientific Article Covering Immune Modulating Interstitial Laser Thermotherapy by CLS’ Co-founder Professor Karl-Göran Tranberg Published in the Journal “Frontiers in Oncology”
July 19, 2021 07:00 ET | Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced that a review...
CLS-Logo-1.jpg
Scientific Article Covering Immune Modulating Interstitial Laser Thermotherapy by CLS’ Co-founder Professor Karl-Göran Tranberg Published in the Journal “Frontiers in Oncology”
July 19, 2021 02:00 ET | Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, July 19, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced that a review...
22157.jpg
TCR-based Therapies Market Research Report 2021
July 16, 2021 04:58 ET | Research and Markets
Dublin, July 16, 2021 (GLOBE NEWSWIRE) -- The "TCR-based Therapies Market by Target Indications, Target Antigens, Key Players and Key Geographies, Industry Trends and Global Forecasts, 2021-2030"...
22157.jpg
Global $10 Billion Bi-Specific MAbS Markets, 2015-2020, 2020-2025F, 2030F
June 23, 2021 05:48 ET | Research and Markets
Dublin, June 23, 2021 (GLOBE NEWSWIRE) -- The "Bi-Specific MAbS Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The global...
Qu Biologics.png
Qu Biologics Files Important New IP for the Treatment of Post-Surgical Immune Dysfunction and Prevention of Cancer Metastasis
May 12, 2021 09:00 ET | Qu Biologics, Inc.
VANCOUVER, British Columbia, May 12, 2021 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a private clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform...